Cryoablation Provides Superior Local Control of Primary Hepatocellular Carcinomas of >2 cm Compared with Radiofrequency Ablation and Microwave Coagulation Therapy: An Underestimated Tool in the Toolbox

Annals of Surgical Oncology

Volumn 22, Issue 4, 2015, Pages 1294-1300

  Ei, Shigenori ^a   Hibi, Taizo ^a   Tanabe, Minoru ^b   Itano, Osamu ^a   Shinoda, Masahiro ^a   Kitago, Minoru ^a   Abe, Yuta ^a   Yagi, Hiroshi ^a   Okabayashi, Koji ^a   Sugiyama, Daisuke ^a   Wakabayashi, Go ^c   Kitagawa, Yuko ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL BLEEDING; AGED; ARTICLE; ASCITES; BONE METASTASIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CANCER THERAPY; CRYOABLATION; DISTANT METASTASIS; DUODENUM ULCER; FEMALE; HEMATOTHORAX; HUMAN; HYPERTENSION; LIVER CELL CARCINOMA; LIVER RESECTION; LOCAL RECURRENCE FREE SURVIVAL; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROWAVE COAGULATION THERAPY; OVERALL SURVIVAL; PLEURA EFFUSION; PNEUMONIA; PORTAL VEIN THROMBOSIS; RADIOFREQUENCY ABLATION; SURGICAL INFECTION; THROMBOCYTOPENIA; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COMPARATIVE STUDY; CRYOSURGERY; FOLLOW UP; LIVER NEOPLASMS; MICROWAVE RADIATION; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL RATE; THERAPEUTIC USE; TUMOR RECURRENCE;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CRYOSURGERY; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; LIVER NEOPLASMS; MALE; MICROWAVES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84925534972     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-4114-7     Document Type: Article

References (33)

1. Tateishi R, Shiina S, Ohki T, et al. Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation. J Gastroenterol. 2009;44(Suppl 19):142–146.
2. Shiina S, Tateishi R, Arano T, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012;107:569–577.
3. Takami Y, Ryu T, Wada Y, Saitsu H. Evaluation of intraoperative microwave coagulo-necrotic therapy (MCN) for hepatocellular carcinoma: a single center experience of 719 consecutive cases. J Hepatobiliary Pancreat Sci. 2013;20:332–341.
4. Simo KA, Sereika SE, Newton KN, Gerber DA. Laparoscopic-assisted microwave ablation for hepatocellular carcinoma: safety and efficacy in comparison with radiofrequency ablation. J Surg Oncol. 2011;104:822–829.
5. Lam VW, Ng KK, Chok KS, et al. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg. 2008;207:20–29.
6. Tashiro H, Aikata H, Waki K, et al. Treatment strategy for early hepatocellular carcinomas: comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection. J Surg Oncol. 2011;104:3–9.
7. Shimizu T, Sakuhara Y, Abo D, et al. Outcome of MR-guided percutaneous cryoablation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2009;16:816–823.
8. Chen HW, Lai EC, Zhen ZJ, Cui WZ, Liao S, Lau WY. Ultrasound-guided percutaneous cryotherapy of hepatocellular carcinoma. Int J Surg. 2011;9:188–191.
9. Yang Y, Wang C, Lu Y, et al. Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2012;19:674–684.
10. Pearson AS, Izzo F, Fleming RY, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg. 1999;178:592–599.
11. Bilchik AJ, Wood TF, Allegra D, et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms. A proposed algorithm. Arch Surg. 2000;135:657–664.
12. Adam R, Hagopian EJ, Linhares M, et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg. 2002;137:1332–1340.
13. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–196.
14. Shi M, Zhang CQ, Zhang YQ, Liang XM, Li JQ. Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World J Surg. 2004;28:376–381.
15. Kim SK, Rhim H, Kim YS, Koh BH, Cho OK, Seo HS, Kim Y. Radiofrequency thermal ablation of hepatic tumors: pitfalls and challenges. Abdom Imaging. 2005;30:727–733.
16. Hong K, Georgiades C. Radiofrequency ablation: mechanism of action and devices. J Vasc Interv Radiol. 2010;21:S179–86.
17. Kim JH, Won HJ, Shin YM, Kim SH, Yoon HK, Sung KB, Kim PN. Medium-sized (3.1–5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone. Ann Surg Oncol. 2011;18:1624–1629.
18. Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN. Hepatocellular carcinomas 2–3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone. Eur J Radiol. 2012;8:e189–193.
19. Seifert JK, Junginger T, Morris DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb. 1998;43:141–154.
20. Bhardwaj N, Strickland AD, Ahmad F, Atanesyan L, West K, Lloyd DM. A comparative histological evaluation of the ablations produced by microwave, cryotherapy and radiofrequency in the liver. Pathology. 2009;41:168–172.
21. Eggstein S, Neeff H, Szarzynski M, et al. Hepatic cryotherapy involving the vena cava. Experimental study in a pig liver model. Eur Surg Res. 2003;35:67–74.
22. Jungraithmayr W, Szarzynski M, Neeff H, et al. Significance of total vascular exclusion for hepatic cryotherapy: an experimental study. J Surg Res. 2004;116:32–41.
23. Erinjeri JP, Clark TW. Cryoablation: mechanism of action and devices. J Vasc Interv Radiol. 2010;21:S187–S191.
24. Lubner MG, Brace CL, Hinshaw JL, Lee FT Jr. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol. 2010;21:S192–S203.
25. Awad MM, Devgan L, Kamel IR, Torbensen M, Choti MA. Microwave ablation in a hepatic porcine model: correlation of CT and histopathologic findings. HPB (Oxford). 2007;9:357–362.
26. Shibata T, Niinobu T, Ogata N. Comparison of the effects of in-vivo thermal ablation of pig liver by microwave and radiofrequency coagulation. J Hepatobiliary Pancreat Surg. 2000;7:592–598.
27. Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30:61–74.
28. Kudo M, Izumi N, Kokudo N, et al. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis. 2011;29:339–364.
29. Osada S, Yoshida K, Saji S. A novel strategy by cryoablation for advanced hepatoma. Anticancer Res 2009;29:5203–5209.
30. Clavien PA, Lesurtel M, Bossuyt PM, et al. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol. 2012;13:e11–e22.
31. Yao FY, Kerlan RK Jr, Hirose R, et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology. 2008;48:819–827.
32. Heckman JT, Devera MB, March JW, et al. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann Surg Oncol. 2008;15:3169–177.
33. Belghiti J, Carr BI, Greig PD, Lencioni R, Poon RT. Treatment before liver transplantation for HCC. Ann Surg Oncol. 2008;15:993–1000.